|
1
|
Parkin DM, Pisani P and Ferlay J:
Estimates of the worldwide incidence of 25 major cancers in 1990.
Int J Cancer. 80:827–841. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parsonnet J, Friedman GD, Vandersteen DP,
et al: Helicobacter pylori infection and the risk of gastric
carcinoma. N Engl J Med. 325:1127–1131. 1991. View Article : Google Scholar
|
|
3
|
No authors listed. NIH Consensus
Conference: Helicobacter pylori in peptic ulcer disease. NIH
Consensus Development Panel on Helicobacter pylori in Peptic
Ulcer Disease. JAMA. 272:65–69. 1994.
|
|
4
|
Uemura N, Okamoto S, Yamamoto S, et al:
Helicobacter pylori infection and the development of gastric
cancer. N Engl J Med. 345:784–789. 2001. View Article : Google Scholar
|
|
5
|
El-Omar EM, Carrington M, Chow WH, et al:
Interleukin-1 polymorphisms associated with increased risk of
gastric cancer. Nature. 404:398–402. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu MS, Wu CY, Chen CJ, Lin MT, Shun CT and
Lin JT: Interleukin-10 genotypes associate with the risk of gastric
carcinoma in Taiwanese Chinese. Int J Cancer. 104:617–623. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ohyauchi M, Imatani A, Yonechi M, et al:
The polymorphism interleukin 8 −251 A/T influences the
susceptibility of Helicobacter pylori related gastric
diseases in the Japanese population. Gut. 54:330–335. 2005.
|
|
8
|
Arisawa T, Tahara T, Shibata T, et al:
Functional promoter polymorphisms of the macrophage migration
inhibitory factor gene in gastric carcinogenesis. Oncol Rep.
19:223–228. 2008.PubMed/NCBI
|
|
9
|
Arisawa T, Tahara T, Shiroeda H, et al:
Genetic polymorphisms of IL17A and pri-microRNA-938,
targeting IL17A 3′-UTR, influence susceptibility to gastric
cancer. Hum Immunol. 73:747–752. 2012.
|
|
10
|
Kiechl S, Lorenz E, Reindl M, et al:
Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med.
347:185–192. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hoshino K, Takeuchi O, Kawai T, et al:
Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are
hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps
gene product. J Immunol. 162:3749–3752. 1999.PubMed/NCBI
|
|
12
|
Keates S, Hitti YS, Upton M and Kelly CP:
Helicobacter pylori infection activates NF-kappaB in gastric
epithelial cells. Gastroenterology. 113:1099–1109. 1997. View Article : Google Scholar
|
|
13
|
Hatz RA, Rieder G, Stolte M, et al:
Pattern of adhesion molecule expression on vascular endothelium in
Helicobacter pylori-associated antral gastritis.
Gastroenterology. 112:1908–1919. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Maeda S, Yoshida H, Ogura K, et al: H
pylori activates NF-kappaB through a signaling pathway
involving IkappaB kinases, NF-kappaB-inducing kinase, TRAF2, and
TRAF6 in gastric cancer cells. Gastroenterology. 119:97–108. 2000.
View Article : Google Scholar
|
|
15
|
Smith MG, Hold GL, Tahara E and El-Omar
EM: Cellular and molecular aspects of gastric cancer. World J
Gastroenterol. 12:2979–2990. 2006.
|
|
16
|
Le Beau MM, Ito C, Cogswell P, Espinosa R
III, Fernald AA and Baldwin AS Jr: Chromosomal localization of the
genes encoding the p50/p105 subunits of NF-kappaB (NFKB2)
and the I kappaB/MAD-3 (NFKBI) inhibitor of NF-kappaB to
4q24 and 14q13, respectively. Genomics. 14:529–531. 1992.PubMed/NCBI
|
|
17
|
Zou YF, Yuan FL, Feng XL, et al:
Association between NFKB1 −94ins/del ATTG promoter
polymorphism and cancer risk: a meta-analysis. Cancer Invest.
29:78–85. 2011.
|
|
18
|
Arisawa T, Tahara T, Shiroeda H, et al:
NFKB1 polymorphism is associated with age-related gene
methylation in Helicobacter pylori-infected subjects. Int J
Mol Med. 30:255–262. 2012.
|
|
19
|
Dixon MF, Genta RM, Yardley JH and Correa
P: Classification and grading of gastritis. The updated Sydney
System International Workshop on the Histopathology of Gastritis,
Houston 1994. Am J Surg Pathol. 20:1161–1181. 1996.PubMed/NCBI
|
|
20
|
Hayashi R, Tahara T, Yamaaki T, et al:
−449 C>G polymorphism of NFKB1 gene, coding nuclear
factor-kappaB, is associated with the susceptibility to ulcerative
colitis. World J Gastroenterol. 47:6981–6986. 2012.
|
|
21
|
Lauren P: The two histologic main types of
gastric carcinoma: diffuse and so-called intestinal type carcinoma.
An attempt at a histo-clinical classification. Acta Pathol
Microbiol Scand. 64:31–49. 1965.PubMed/NCBI
|
|
22
|
Yoshimura T, Shimoyama T, Fukuda S, Tanaka
M, Axon AT and Munakata A: Most gastric cancer occurs on the distal
side of the endoscopic atrophic border. Scand J Gastroenterol.
34:1077–1081. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Go MF: Review article: Natural history and
epidemiology of Helicobacter pylori infection. Aliment
Pharmacol Ther. 16(Suppl 1): S3–S15. 2002. View Article : Google Scholar
|
|
24
|
Kong X, Wang JL, Chen HM and Fang JY:
Comparison of the clinicopathological characteristics of young and
elderly patients with gastric carcinoma: a meta analysis. J Surg
Oncol. 106:346–352. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Karban AS, Okazaki T, Panhuysen CI, et al:
Functional annotation of a novel NFKB1 promoter polymorphism
that increases risk for ulcerative colitis. Hum Mol Genet.
13:35–45. 2004.PubMed/NCBI
|
|
26
|
Li H, Gao L, Shen Z, et al: Association
study of NFKB1 and SUMO4 polymorphisms in Chinese patients with
psoriasis vulgaris. Arch Dermatol Res. 300:425–433. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lo SS, Chen JH, Wu CW and Lui WY:
Functional polymorphism of NFKB1 promoter may correlate to
the susceptibility of gastric cancer in aged patients. Surgery.
145:280–285. 2009.
|
|
28
|
Kurylowicz A, Hiromatsu Y,
Jurecka-Lubieniecka B, et al: Association of NFKB1
−94ins/del ATTG promoter polymorphism with susceptibility to and
phenotype of Graves’ disease. Genes Immun. 8:532–538. 2007.
|
|
29
|
Andersen V, Christensen J, Overvad K,
Tjønneland A and Vogel U: Polymorphisms in NFκB, PXR, LXR and risk
of colorectal cancer in a prospective study of Danes. BMC Cancer.
10:4842010.
|
|
30
|
Mirza MM, Fisher SA, Onnie C, et al: No
association of the NFKB1 promoter polymorphism with
ulcerative colitis in a British case control cohort. Gut.
54:1205–1206. 2005.PubMed/NCBI
|
|
31
|
Glas J, Török HP, Tonenchi L, et al: Role
of the NFKB1 −94ins/delATTG promoter polymorphism in IBD and
potential interactions with polymorphisms in the CARD15/NOD2, IKBL,
and IL-1RN genes. Inflamm Bowel Dis. 12:606–611. 2006.
|
|
32
|
Bajwa EK, Cremer PC, Gong MN, et al: An
NFKB1 promoter insertion/deletion polymorphism influences
risk and outcome in acute respiratory distress syndrome among
Caucasians. PLoS One. 6:e194692011.PubMed/NCBI
|
|
33
|
Pereira SG and Oakley F: Nuclear
factor-kappaB1: regulation and function. Int J Biochem Cell Biol.
40:1425–1430. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
de Winther MP, Kanters E, Kraal G and
Hofker MH: Nuclear factor kappaB signaling in atherogenesis.
Arterioscler Thromb Vasc Biol. 25:904–914. 2005.PubMed/NCBI
|
|
35
|
Lin L, DeMartino GN and Greene WC:
Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome.
Cell. 92:819–828. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Perkins ND: Integrating cell-signalling
pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol.
8:49–62. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hayden MS and Ghosh S: Shared principles
in NF-kappaB signaling. Cell. 132:344–362. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gadjeva M, Tomczak MF, Zhang M, et al: A
role for NF-kappaB subunits p50 and p65 in the inhibition of
lipopolysaccharide-induced shock. J Immunol. 173:5786–5793. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Han W, Joo M, Everhart MB, et al: Myeloid
cells control termination of lung inflammation through the
NF-kappaB pathway. Am J Physiol Lung Cell Mol Physiol.
296:L320–L327. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sasaki N, Morisaki T, Hashizume K, et al:
Nuclear factor-kappaB p65 (RelA) transcription factor is
constitutively activated in human gastric carcinoma tissue. Clin
Cancer Res. 7:4136–4142. 2001.PubMed/NCBI
|
|
41
|
Kang MH, Oh SC, Lee HJ, et al: Metastatic
function of BMP-2 in gastric cancer cells: the role of PI3K/AKT,
MAPK, the NF-κB pathway, and MMP-9 expression. Exp Cell Res.
317:1746–1762. 2011.PubMed/NCBI
|
|
42
|
Qin Y, Li L, Chen J, et al: Fentanyl
inhibits progression of human gastric cancer MGC-803 cells by NF-κB
downregulation and PTEN upregulation in vitro. Oncol Res. 20:61–69.
2012.PubMed/NCBI
|
|
43
|
Kim JG, Sohn SK, Chae YS, et al: No
association of the NFKB1 insertion/deletion promoter
polymorphism with survival in patients with gastric cancer. Jpn J
Clin Oncol. 39:497–501. 2009.
|
